Activation of the Α 2B Adrenoceptor by the Sedative Sympatholytic Dexmedetomidine

Daopeng Yuan,Zhongmin Liu,Jonas Kaindl,Shoji Maeda,Jiawei Zhao,Xiaoou Sun,Jun Xu,Peter Gmeiner,Hong-Wei Wang,Brian K. Kobilka

DOI: https://doi.org/10.1038/s41589-020-0492-2

IF: 14.8

2020-01-01

Nature Chemical Biology

Abstract:The α 2 adrenergic receptors (α 2 ARs) are G protein-coupled receptors (GPCRs) that respond to adrenaline and noradrenaline and couple to the Gi/o family of G proteins. α 2 ARs play important roles in regulating the sympathetic nervous system. Dexmedetomidine is a highly selective α 2 AR agonist used in post-operative patients as an anxiety-reducing, sedative medicine that decreases the requirement for opioids. As is typical for selective αAR agonists, dexmedetomidine consists of an imidazole ring and a substituted benzene moiety lacking polar groups, which is in contrast to βAR-selective agonists, which share an ethanolamine group and an aromatic system with polar, hydrogen-bonding substituents. To better understand the structural basis for the selectivity and efficacy of adrenergic agonists, we determined the structure of the α 2B AR in complex with dexmedetomidine and Go at a resolution of 2.9 Å by single-particle cryo-EM. The structure reveals the mechanism of α 2 AR-selective activation and provides insights into Gi/o coupling specificity.